Skip to main content
. 2019 Nov 6;4(1):46–53. doi: 10.1002/rth2.12275

Figure 3.

Figure 3

Reduction of fibrinolytic factors in euglobulin fraction. α2AP, α2‐antiplasmin; α2MG, α2‐macroglobulin; aPAI‐1, active form of plasminogen activator inhibitor‐1; EuFr, euglobulin fraction; PFP, platelet free plasma; t‐PA, tissue‐type plasminogen activator